Ultralife shareholders elect all directors, approve say-on-pay, set advisory vote frequency at 3 years

The Company’s shareholders indicated their preference, on a non-binding advisory basis, that the frequency of future advisory votes on executive compensation be “3 Years”. The number of shares that (i) voted for 1 Year, (ii) voted for 2 Years, (iii) voted for 3 Years, and (iv) abstained from the vote, are set forth in the table below. 1 Year 2 Years 3 Years Abstain 2,803,398 30,850 8,390,107 17,029

The Company’s stockholders ratified the selection of the Company’s independent registered public accounting firm as Freed Maxick CPAs, P.C. for 2023. The number of shares that (i) voted for the ratification of the accounting firm, (ii) voted against the ratification, and (iii) abstained from the vote are set forth in the table below. For Against Abstain 13,565,365 15,728 14,963

The Company’s stockholders elected five Directors, all of whom constitute the Company’s entire Board of Directors, to serve for a term of one year and until their successors are duly elected and qualified. The number of shares that (i) voted for the election of each Director, (ii) withheld authority to vote for each Director, and (iii) were broker non-votes, are set forth in the table below. Director For Withheld Broker Non-Votes Michael E. Manna Janie Goddard 11,145,045 11,152,413 96,339 88,971 2,354,672 2,354,672 Thomas L. Saeli 10,310,510 930,874 2,354,672 Robert W. Shaw II 10,971,487 269,897 2,354,672 Bradford T. Whitmore 10,956,195 285,189 2,354,672

The Company’s shareholders approved an advisory resolution on executive compensation. The number of shares that (i) voted for the resolution, (ii) voted against the resolution, (iii) abstained from the vote, and (iv) were broker non-votes, are set forth in the table below. For Against Abstain Broker Non-Votes 11,040,202 162,753 38,429 2,354,672